Figure 1From: Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial Model-based adjusted survival curves, per GOLD stage 2, 3 and 4. Back to article page